R127750-50mgRiociguat
面议
- 阿拉丁
- 生产商
- R127750-50mg
- 现货
- 全国
规格 |
---|
耗材描述
- 分子式 C20H19FN8O2
- 分子量422.42
属性
溶解性 | DMSO |
存贮条件 | 储存温度-20°C |
描述
应用 | Riociguat (BAY 63-2521)是可溶的鸟苷酸环化酶刺激剂。 |
生化机理 | Riociguat (BAY 63-2521; BAY 632521) is a novel drug that is currently in clinical development by Bayer. Riociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC). At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators. |
别名 | 利奥西呱;N-[4,6-二氨基-2-[1-[(2-氟苯基)甲基]-1H-吡唑并[3,4-B]吡啶-3-基]-5-嘧啶基]-N-甲基氨基甲酸甲酯;BAY 63-2521; BAY 632521;N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester |
猜你喜欢
感兴趣产品